Brief: Giant Biogene Holding Posts FY Gross Profit RMB 4,546.9 Million
26/03/2025 15:19
March 26 (Reuters) - Giant Biogene Holding Co Ltd 2367.HK: FY GROSS PROFIT RMB 4,546.9 MILLION FY EPS RMB 2.06 FY NET INCOME RMB 2,061.7 MILLION FY GROSS MARGIN 82.1% FY BASIC EPS RMB 2.1 FY CAPEX RMB 132.8 MILLION FINAL DIVIDENDS OF RMB0.6021 PER ORDINARY SHARE SPECIAL DIVIDENDS OF RMB0.5921 PER ORDINARY SHARE. Further company coverage: 2367.HK ((Reuters.Briefs@thomsonreuters.com))
Recent news on Giant Biogene Holding
See all newsGiant Biogene's profit drops on higher distribution expenses
Brief: Giant Biogene Says Cross-Linked Recombinant Collagen Implant Receives China Medical Device Registration Certificate
Brief: Giant Biogene To Distribute Final Dividends Of Rmb0.5390 Per Share
Brief: Giant Biogene's Unit Received NMPA Medical Device Registration Certificate For Recombinant Collagen, Sodium Hyaluronate Solution
HK-listed Giant Biogene jumps on share buyback plan